Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Trial ID or NCT#

NCT00398177,,,,,,,,

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Official Title

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.* Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).* A routine procedure for tissue collection is planned.* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
  1. * Patients without NHL or Hodgkin's disease

Investigator(s)

Ronald Levy, MD
Ronald Levy, MD
Medical oncologist, Lymphoma specialist
Robert K. and Helen K. Summy Professor in the School of Medicine
Michael Khodadoust
Michael Khodadoust
Lymphoma specialist, Cutaneous oncology specialist, Hematologist, Hematologist-Oncologist
Assistant Professor of Medicine (Oncology) and of Dermatology
Ash A. Alizadeh, MD/PhD
Ash A. Alizadeh, MD/PhD
Medical oncologist, Lymphoma specialist, Cancer geneticist
Moghadam Family Professor

Contact us to find out if this trial is right for you.

Contact

Ami Okada
650-725-4968